Patents Assigned to Ascelia Pharma AB
  • Publication number: 20220257802
    Abstract: The present invention relates to a compressed solid composition for MRI comprising a physiologically acceptable manganese (II) compound, its preparation and use for preparing an oral solution.
    Type: Application
    Filed: June 8, 2020
    Publication date: August 18, 2022
    Applicant: Ascelia Pharma AB
    Inventors: Bent Højgaard, Magnus Olafsson Corfitzen, Dorthe Da Graca Couto Thrige
  • Patent number: 10912847
    Abstract: The present invention relates to a compressed solid composition for MRI comprising a physiologically acceptable manganese (II) compound, its preparation and use for preparing an oral solution.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: February 9, 2021
    Assignee: Ascelia Pharma AB
    Inventors: Bent Højgaard, Magnus Olafsson Corfitzen, Dorthe Da Graca Couto Thrige